Recently, through the comprehensive analysis of the association between different PSA ranges and DFS under different treatment modalities, a multicenter study identified PSA <0.2 ng/ml at 4 years after LDR prostate BT as a threshold value to predict the long-term (10–15 years) freedom from prostate cancer (149). The gene discussed is KLK3; the disease is prostate cancer.